Douglas T. Sheehy
2019 - Aimmune Therapeutics
In 2019, Douglas T. Sheehy earned a total compensation of $1.9M as General Counsel and Secretary General Counsel and Secretary at Aimmune Therapeutics, a 40% decrease compared to previous year.
Compensation breakdown
| Bonus | $3,852 |
|---|---|
| Non-Equity Incentive Plan | $173,041 |
| Option Awards | $1,060,530 |
| Salary | $401,300 |
| Stock Awards | $296,500 |
| Other | $2,000 |
| Total | $1,937,223 |
Sheehy received $1.1M in option awards, accounting for 55% of the total pay in 2019.
Sheehy also received $3.9K in bonus, $173K in non-equity incentive plan, $401.3K in salary, $296.5K in stock awards and $2K in other compensation.
Rankings
In 2019, Douglas T. Sheehy's compensation ranked 6,110th out of 13,971 executives tracked by ExecPay. In other words, Sheehy earned more than 56.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,110 out of 13,971 | 56th |
Division Manufacturing | 2,295 out of 5,701 | 60th |
Major group Chemicals And Allied Products | 832 out of 2,200 | 62nd |
Industry group Drugs | 702 out of 1,886 | 63rd |
Industry Pharmaceutical Preparations | 518 out of 1,398 | 63rd |
Source: SEC filing on April 9, 2020.
Sheehy's colleagues
We found four more compensation records of executives who worked with Douglas T. Sheehy at Aimmune Therapeutics in 2019.